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Abstract
As a continuation of our research on the development and optimization of the biological activities/proprieties of acridine deriva-
tives, a series of 31 molecules based on 9-aniliioacridines (25 training set and 6 test set) were subjected to 3D quantitative structure
propriety relationship QSPR analyses for their drug-DNA binding proprieties using multiple linear regression (MLR) and multiple
non-linear regression (MNLR). Quantum chemical calculations using density functional theory (B3LYP/6-31G (d) DFT) methods
was performed on the studied compounds and used to calculate the electronic and quantum chemical parameters.
The models were used to predict the association constant of the DNA drug binding of the test set compounds, and the agreement
between the experimental and predicted values was verified. The descriptors determined by QSPR studies were used for the study
and design of new compounds. The statistical results indicate that the predicted values were in good agreement with the experimental
results (r  = 0.935 and r  = 0.936 for MLR and MNLR, respectively). To validate the predictive power of the resulting models, the
external validation multiple correlation coefficients were 0.932 and 0.939 for the MLR and the MNLR, respectively. These results
show that both models possess a favourable estimation stability and good prediction power.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Taibah University. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The ease of synthesis, attractive colouration and
crystallinity of acridine derivatives has long attracted
the attention of medicinal chemists. The acridine
family includes a wide range of planar tri-cyclic aro-
matic molecules with various biological properties and
consists of a nitrogen atom (N-atom) in its hetero-behalf of Taibah University. This is an open access article under the
cyclic nucleus. The natural and synthetic compounds
of the acridine family are well known therapeutic
agents due to their wide range of pharmacologi-
cal and biological activities, including anti-leishmanial
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1,2], anti-microbial [3], anti-oxidant [4], anti-malarial
5], anti-inflammatory [6], analgesic [7], anti-parasitic
8], anti-tumoural [9], anti-bacterial or anti-cancer
hemotherapy [10–13] activities, among others.
The diversity of the biological and pharmacological
ctivities has given acridines a respectable reputation in
hemotherapy in the 20th century [14].
One of the important phenomena of DNA is their
bility to reversibly bind planar molecules that can be
nserted between the base pairs of the double helix [15].
cridines are fused linear tri-cyclic aromatic molecules
ith planar geometry that bind tightly, but reversibly,
o DNA by intercalating between adjacent base pairs
16,17]. The driving force for this binding comes pri-
arily from stacking interactions between the acridine
ucleus and the DNA bases and is sufficiently large to
hysically unwind the DNA double helix to accommo-
ate the inserted ligand. The majority of the biological
ffects of acridine derivatives are considered to result
rom this mode of non-covalent interactions with DNA
18].
Generally, hetero-aromatic molecules bind to DNA
y intercalating (i.e., a non-covalent interaction in which
he drug is held rigidly and perpendicular to the helix
xis) and stacking between the base pairs of the double
elix. The principal driving forces for the intercalation
re stacking and charge-transfer interactions, but hydro-
en bonding and electrostatic forces also play a role in
tabilization [19].
9-Anilinoacridines, as intercalators of double-
tranded (duplex) DNA, have been explored extensively
s antitumour agents. In particular, m-AMSA and CI-921
re, in fact, used clinically for the treatment of leukaemia
20–23].
To discover new active antitumour compounds, we
xamined the DNA-ethidium fluorescence quenching
ffect of these compounds and found a substance that
xhibits a stronger fluorescence quenching effect than
-ASMA. Moreover, it has been established that the
uorescence quenching demonstrates a very good cor-
elation with antitumour activity [24–26].
In an investigation of the structure propriety relation-
hips in the (AMSA) tumour inhibitory analogues, the
NA binding properties of a series of 9-aniliioacridines
as determined by drug competition with the fluo-
ochrome ethidium for available sites. The decrease in
uorescence of a DNA-ethidium complex by the addi-
ion of a drug is due to both the drug displacement of the
ound ethidium and the quenching of the fluorescence
f the bound ethidium by the bound drug. The measure-
ent of both factors allows the drug-DNA association
onstants (K) to be determined [27,28].ity for Science 10 (2016) 868–876 869
The experiment is a direct method of obtaining the
activity/propriety data of organic compounds. However,
this approach suffers from many deficiencies, includ-
ing the requirement of myriads of trial organisms, high
cost, long period of time, significant variations in the
measured values between laboratories, and so on. Con-
sequently, it would be impossible to determine the
drug-DNA association constants of all of the organic
compounds by experimentation. As new compounds are
emerging, other difficulties will follow. Therefore, it
is necessary to use theoretical research to compensate
for the disadvantages of experimentation and to pre-
dict the data for compounds quickly and precisely. In
this research paper, we focus on the drug-DNA binding
constants of some acridine derivatives.
With the rapid development of computer science
and theoretical quantum chemical studies, the quan-
tum chemical parameters of compounds can be obtained
quickly and precisely by computation. These structural
parameters, along with the introduction of quantitative
structure activity/propriety relationship (QAPR/QSPR)
models, can increase the interpretability and pre-
dictability of the activities/proprieties of new organic
compounds.
In this work, we attempt to establish a quantitative
structure propriety relationship for the association con-
stant (K) of drug binding to DNA by studying a series of
31 substituted 9-aniliioacridine derivatives. We accord-
ingly propose quantitative models and try to interpret
the propriety of the compounds relying on multivariate
statistical analyses. Thus, we can predict the association
constant (K) for drug binding to DNA.
2.  Material  and  methods
2.1.  Experimental  data
To determine a quantitative structure function
relationship, we studied a series of 31 selected 9-
aniliioacridine derivatives that were synthesized and that
had their antitumour activity evaluated by Bruce et al.
[27]. Twenty-five molecules were selected to propose the
quantitative model (training set) as well as 6 compounds
that were not used in the training set were selected ran-
domly served to test the performance of the proposed
model (test set). In reality, Bruce et al. proposed 65 com-
pounds; the remaining compounds had structures that
differed from the structures required for this study.
Fig. 1 shows the chemical structures of the studied
compounds, and the experimental association constants
for the drug binding to DNA (the concentration of drug
870 S. Chtita et al. / Journal of Taibah Univers
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Fig. 1. Chemical structure of the studied compounds.
To explain the structure-activity relationship, these 12
descriptors were calculated for the 31 molecules using
the Gaussian 03W and Gauss View software. The studyneeded to displace 50% of the ethidium) of the studied
compounds were taken from Ref. [27] (Table 1).
2.2.  Computational  methods
An attempt has been made to correlate the propri-
ety of these compounds with various physicochemical
parameters. DFT (density functional theory) and TD-
DFT methods were used in this study. 3D structures of
the molecules were generated using the Gauss View 3.0,
and then, all of the calculations were performed using
the Gaussian 03 W program series. Geometry optimiza-
tion of the 31 compounds was carried out by a B3LYP
function employing a 6–31G (d) basis set [29,30]. The
geometry of all of the species under investigation was
determined by optimizing all of the geometrical variables
without any symmetry constraints [31].
Table 1
Observed Log K for the 9-aniliioacridine derivatives.
Compound R Log K Compo
1 NO2 5.48 17 
2 SO2CH3 5.86 18 
3 CN 5.70 19 
4 SO2NHCH3 5.82 20 
5 SO2NH2 5.96 21a
6a COCH3 5.87 22 
7 COOCH3 5.88 23 
8 CONH2 5.83 24 
9 F 5.90 25 
10 Cl 5.99 26a
11a Br 6.02 27 
12 NHSO2CH3 6.15 28 
13 NHSO2C6H5 6.20 29 
14 H 5.86 30 
15 NHCOCH3 6.30 31a
16a NHCOOCH3 6.36 K: Ass
a Tested compounds (test set).ity for Science 10 (2016) 868–876
2.3.  Calculation  of  the  molecular  descriptors
From the results of the DFT calculations, the quan-
tum chemistry descriptors were obtained for the model
building as follows: the total energy, ET (eV); highest
occupied molecular orbital energy, EHOMO (eV); low-
est unoccupied molecular orbital energy, ELUMO (eV);
difference in absolute value Gap (eV); dipole moment, μ
(Debye); absolute hardness, η  (eV); absolute electroneg-
ativity, χ (eV); electrophilicity index, ω  (eV); and sum
of the negative charges on the molecule (TNC) were
deduced from the stable structure of the neutral form.
η, χ  and ω  were determined from [32]:
η  = ELUMO  −  EHOMO
2
;
χ  = ELUMO  +  EHOMO
2
; ω  = χ
2
2η
The transition energies were calculated in the ground-
state with excited-state geometries using TD-DFT
calculations on the fully optimized geometries. The
results obtained gave us the absorption maximum, max
(nm), their corresponding activation energy, Ea  (eV),
and the factor oscillation strengths, S.O.
2.4.  Statistical  analysisthat we conducted consists of multiple linear regression
und R Log K
CH3 5.99
NHCOC6H5 6.20
NHCONHCH3 6.24
NHCONHC6H5 6.37
OCH3 6.12
OH 6.28
NH(CH2)5CH3 6.43
NH(CH2)3CH3 6.45
NH(CH2)2CH3 6.35
NHCH2CH3 6.44
NH2 6.31
N(CH3)2 6.51
NHCH3 6.55
NCH3SO2CH3 5.89
NHSO2C6H4-p-NH2 6.30
ociation constant for drug binding to DNA
S. Chtita et al. / Journal of Taibah University for Science 10 (2016) 868–876 871
Table 2
Values of the parameters obtained by DFT/TD-DFT calculation for the training set.
No. ET μ EHOMO ELUMO Gap η χ ω λmax S.O. Ea TNC
1 −26,428.147 4.957 −5.552 −2.493 3.059 1.530 −4.023 5.289 423.01 0.257 2.931 −4.264
2 −38,906.463 5.218 −5.744 −2.314 3.430 1.715 −4.029 4.733 410.00 0.185 3.024 −7.178
3 −25,420.014 5.174 −5.740 −2.343 3.397 1.698 −4.041 4.808 415.77 0.191 2.982 −4.442
4 −40,412.372 4.552 −5.696 −2.176 3.420 1.710 −3.986 4.645 412.38 0.185 3.007 −7.643
5 −39,342.774 3.910 −5.681 −2.266 3.416 1.708 −3.973 4.622 412.51 0.187 3.006 −7.346
7 −29,110.685 3.367 −5.524 −2.157 3.367 1.683 −3.841 4.381 420.84 0.211 2.946 −5.624
8 −27,500.440 4.854 −5.496 −2.134 3.363 1.681 −3.815 4.328 420.74 0.201 2.947 −5.625
9 −25,610.109 2.013 −5.345 −2.011 3.333 1.667 −3.678 4.058 422.63 0.167 2.934 −4.499
10 −35,415.609 2.172 −5.449 −2.105 3.344 1.672 −3.777 4.265 423.13 0.179 2.930 −4.127
12 −40,412.465 5.953 −5.416 −2.104 3.312 1.656 −3.760 4.268 429.74 0.193 2.885 −7.770
13 −45,629.550 6.683 −5.392 −2.088 3.304 1.652 −3.740 4.234 431.85 0.210 2.871 −8.251
14 −22,910.013 2.378 −5.298 −1.957 3.340 1.670 −3.627 3.939 422.14 0.168 2.937 −4.316
15 −28,569.981 3.238 −5.386 −2.108 3.278 1.639 −3.747 4.284 435.87 0.192 2.845 −6.095
17 −23,979.846 2.724 −5.218 −1.913 3.304 1.652 −3.565 3.847 428.57 0.181 2.893 −4.780
18 −33,787.105 2.924 −5.368 −2.095 3.273 1.637 −3.731 4.254 438.24 0.205 2.829 −6.547
19 −30,076.151 2.353 −5.247 −2.014 3.233 1.616 −3.631 4.078 442.79 0.199 2.800 −6.577
20 −35,293.400 2.335 −5.263 −2.016 3.248 1.624 −3.639 4.079 440.90 0.198 2.812 −7.251
22 −24,956.583 3.981 −5.110 −1.852 3.258 1.629 −3.481 3.718 434.13 0.178 2.856 −4.846
23 −30,834.393 5.174 −4.785 −1.705 3.080 1.540 −3.245 3.419 467.03 0.186 2.655 −7.512
24 −28,694.939 5.124 −4.789 −1.707 3.082 1.541 −3.248 3.424 466.68 0.184 2.657 −6.615
25 −27,625.214 5.098 −4.794 −1.710 3.084 1.542 −3.252 3.429 466.32 0.181 2.659 −6.167
27 −24,416.119 4.655 −4.900 −1.751 3.149 1.575 −3.326 3.512 453.49 0.176 2.734 −4.964
28 −25,485.689 4.925 −4.813 −1.722 3.091 1.545 −3.267 3.454 464.81 0.174 2.667 −5.244
29 −26,555.202 4.973 −4.743 −1.709 3.034 1.517 −3.226 3.430 474.87 0.181 2.611 −5.522
3 1.65
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MLR) and non-linear regression (MNLR), which are
vailable in the XLSTAT software [33].
The multiple linear regression statistical technique
s used to study the relationship between one depend-
nt variable and several independent variables. It is a
athematical technique that minimizes the differences
etween actual and predicted values. It has also served
o select descriptors that are used as input parameters in
ultiple non-linear regression (MNLR).
The MLR and MNLR techniques were used to predict
he association constant for drug binding to DNA values,
og(K). The equations were justified by the correlation
oefficient (r), the Mean Squared Error (MSE), the Fish-
rs F-statistic (F), and the significance level (F-value)
34].
.  Results  and  discussion
.1.  Data  set  for  analysis
The QSPR analysis was performed using the exper-
mental association constant for drug binding to DNA
alues for the 31 selected molecules as reported by Bruce
t al. [27]; the values of the 12 chemical descriptors are
hown in Table 2.4 −3.785 4.330 431.82 0.188 2.871 −8.063
3.2.  Multiple  linear  regression  (MLR)
To propose a mathematical model and to quantita-
tively evaluate the substituent’s physicochemical effects
on log K for the entire set consisting of 31 molecules,
we submitted the data matrix that was composed of
the 12 variables that corresponded to the 25 molecules
(training set) to a descendent multiple regression
analysis.
The decreasing study of MLR based on the elimina-
tion of descriptors aberrant until a valid model (including
the critical probability: p-value < 0.05 for all descrip-
tors and the model complete). This method used the
coefficients r, r2, MSE and F-values to select the
best regression performance, where r is the correla-
tion coefficient; r2 is the coefficient of determination;
MSE is the mean squared error; and F  is the Fisher
F-statistic.
Treatment with multiple linear regressions is more
accurate because it allows for the structural descrip-
tors for each drug-DNA propriety of the 25 molecules
to be connected to quantitatively evaluate the effect of
the substituent. The selected descriptors are: the low-
est unoccupied molecular orbital energy, ELUMO; the
electrophilicity index, ω; and the activation energy, Ea.
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The QSPR model built using the multiple linear
regression (MLR) method is represented by the follow-
ing equation:
Log K  =  11.484–7.898 ELUMO −  3.495 
− 2.461 Ea (1)
N =  25; r  =  0.935; r2 =  0.873; F  =  48.256;
MSE =  0.011; p-value <  0.0001
A higher correlation coefficient, r, and lower mean
squared error, MSE, indicate that the model is more reli-
able. The Fisher F-test is also used. Given that the p-value
is much smaller than 0.05, we are taking less than a
0.01% risk in assuming that the null hypothesis is wrong.
Therefore, we can conclude, with confidence, that the
model brings a significant amount of information.
The elaborated QSPR model reveals that the associ-
ation constant for the drug-DNA could be explained by
a number of electronic factors (ELUMO,    and Ea). The
negative correlation of these factors with the association
constant for the drug-DNA constants in equation 1 shows
that an increase in the values of these factors implies
a decrease in the value of Log K, i.e., the variation in
Log K  with the descriptor values, which are illustrated
in Fig. 2, show that the lowest unoccupied molecular
orbital, ELUMO, varies in the same way as Log K, so
the activation energy and the electrophilicity index vary
inversely.
The predicted Log(K) values calculated from Eq. (1)
using the optimal MLR model are given in Table 3
in comparison to the observed values. The correlation
between the predicted and observed Log K  (training set
and test set) are illustrated in Fig. 3. The descriptorsFig. 3. Correlations of observed and predicted Log K with MLR (train-
ing set is in blue and test set is in red).
proposed in equation 1 by MLR were therefore used as
the input parameters in the multiple non-linear regression
(MNLR).
3.3.  Multiple  non-linear  regression  (MNLR)
We also used the non-linear regression model to
improve the structure-propriety relationship to quanti-
tatively evaluate the effect of the substituent. We applied
the descriptors proposed by the MLR corresponding to
the 25 molecules (training set) to the data matrix. The
coefficients, R and R2, were used to select the best regres-
sion performance. We used a pre-programmed function
of XLSTAT following:+ (f  X1 +  gX2 +  hX3 +  iX4 +  · · ·)
where a, b, c, d,.  . . represent the parameters and X1, X2,
X3, X4,. . . represent the variables.
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Table 3
The observed, the predicted Log K, and residue according to RLM and RNLM for the 25 acridines derivatives (training set).
Compound Obs RLM RNLM
Log Kobs Log KRLM Residue Log KRNLM Residue
1 5.480 5.472 0.008 5.479 0.001
2 5.860 5.774 0.086 5.751 0.109
3 5.700 5.844 −0.144 5.827 −0.127
4 5.820 5.821 −0.001 5.805 0.015
5 5.960 5.827 0.133 5.811 0.149
7 5.880 5.956 −0.076 5.959 −0.079
8 5.830 5.957 −0.127 5.957 −0.127
9 5.900 5.962 −0.062 5.967 −0.067
10 5.990 5.990 0.000 5.993 −0.003
12 6.150 6.083 0.067 6.092 0.058
13 6.200 6.110 0.090 6.121 0.079
14 5.860 5.944 −0.084 5.945 −0.085
15 6.300 6.157 0.143 6.176 0.124
17 5.990 6.026 −0.036 6.032 −0.042
18 6.200 6.198 0.002 6.210 −0.010
19 6.240 6.245 −0.005 6.260 −0.020
20 6.370 6.228 0.142 6.235 0.135
22 6.280 6.086 0.194 6.094 0.186
23 6.430 6.465 −0.035 6.457 −0.027
24 6.450 6.458 −0.008 6.456 −0.006
25 6.350 6.460 −0.110 6.451 −0.101
27 6.310 6.309 0.001 6.319 −0.009
28 6.510 6.447 0.063 6.440 0.070
2
3
L
N
F
(9 6.550 6.566 
0 5.890 6.114 
The resulting equation:
og K  =  5.381 +  22.320ELUMO +  10.627ω
+ 3.151Ea +  5.445(ELUMO)2 −  1.272(ω)2
−  0.926(Ea)2 (2) =  25; r  =  0.936; r2 =  0.875; MSE =  0.013
5
5.5
6
6.5
7
5 5.5 6 6.5 7
L
og
 K
 (O
bs
)
Pred (Log K)  - RNLM)
ig. 4. Correlations of observed and predicted Log K with MNLR
training set in blue and test set in red).−0.016 6.539 0.011
−0.224 6.123 −0.233
The predicted Log K  values calculated from equation
2 are given in Table 3 in comparison to the observed val-
ues. The correlation between the predicted and observed
Log K values are shown in Fig. 4.
The true predictive power of a QSPR model is to
test their ability to accurately predict the Log K  of com-
pounds from an external test set (compounds that were
not used for the model development). The Log K  values
for the remaining set of 6 compounds were deduced from
the quantitative model proposed using the 25 molecules
(training set) by MLR and MNLR. Their structures are
given in Table 4; the observed and calculated log(K)
values are given in Table 5.
Table 4
The values of the parameters obtained by DFT calculation for the test
set compounds.
No. ELUMO ω Ea
6 −2.195 4.469 2.943
11 −2.109 4.275 2.918
16 −1.962 3.964 2.787
21 −1.831 3.676 2.836
26 −1.700 3.408 2.646
31 −2.013 4.070 2.838
Univers874 S. Chtita et al. / Journal of Taibah 
A comparison of the log(k-test) to the log(k-obs) val-
ues shows that the model made good predictions for the
6 compounds:
MLR MNLR
N = 6 rtest = 0.932 r2test = 0.869 rtest = 0.939 r2test = 0.881From the results obtained by MLR and MNLR, we
can conclude that the model performs well, as further
supported by the results obtained from testing the 6 test
Table 5
The observed, the predicted Log(K), and residue according to MLR and MNL
Compound Obs RLM 
Log Kobs Log KRLM
6 5.870 5.958 
11 6.020 6.013 
16 6.360 6.269 
21 6.120 6.118 
26 6.440 6.483 
31 6.300 6.174 
Table 6
The proposed novel compounds.
No. R ELUMO 
X1 N(C2H2C2H4)2 −2.075 4.
X2 CN −2.343 4.
X3 CF3 −2.204 4.
X4 CCl3 −2.248 4.
X5 CHO −2.294 4.
X6 CBr3 −2.231 4.
X7 CH2F −2.012 4.
X8 CMe3 −1.912 3.
X9 CMe2Ph −1.905 3.
X10 OPh −1.987 4.
X11 Ph −1.998 4.
X12 N(PhCl)2ortho −1.935 3.
X13 N(PhCl)2meta −2.125 4.
X14 N(PhCl)2para −2.115 4.
X15 N(o-C6H4CH3)2 −1.880 3.
X16 NPh2 −1.963 4.
X17 N(m-C6H4CH3)2 −1.941 3.
X18 N(p-C6H4CH3)2 −1.913 3.ity for Science 10 (2016) 868–876
compounds. Even if this good predictive power is the
result of chance, we can claim that this is a positive
result. Accordingly, this model could be applied to all
9-aniliioacridine derivatives in Table 1 and add further
knowledge to improve the search of antitumour drugs.
A comparison of the quality of the MLR and MNLR
models shows that the 2 approaches have a better pre-
dictive capability as they give better results. MLR and
MNLR were able to establish a satisfactory relationship
between the molecular descriptors and the drug-DNA
propriety of the studied compounds.
R for the 6 tested compounds (test set).
RNLM
Residue Log KRNLM Residue
0.088 5.964 0.094
−0.007 6.020 0.000
−0.091 6.276 −0.084
−0.002 6.133 0.013
0.043 6.473 0.033
−0.126 6.180 −0.120
 Ea Log K
RLM RNLM
365 3.707 3.487 3.617
808 2.982 5.843 5.826
482 2.997 5.848 5.841
585 2.979 5.878 5.874
696 2.953 5.917 5.914
550 2.949 5.944 5.945
059 2.929 5.979 5.979
845 2.890 6.034 6.038
830 2.883 6.047 6.053
012 2.853 6.136 6.141
038 2.815 6.220 6.226
920 2.651 6.543 6.536
378 2.582 6.611 6.645
368 2.532 6.687 6.721
824 2.470 6.883 6.835
032 2.415 6.947 6.926
987 2.389 6.997 6.965
929 2.356 7.061 7.010
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QSPR correlates propriety data with the physico-
hemical and/or structural properties of a group of
ompounds. It has been frequently used to predict the
roprieties of new compounds and to design compounds
ith desired properties.
The developed equations can be used for the design of
ew 9-aniliioacridine derivatives with improved associa-
ion constants for DNA drug binding properties (log(K)).
or example, Eq. (1) (for RLM) and Eq. (2) (for RNLM)
ndicated the negative correlation of valance first order
LUMO, ω  and Ea.
If we develop a new compound with higher val-
es than the existing compounds, it may give rise to
he development of more active compounds than those
urrently in use. In this way, we have designed new com-
ounds (Table 6) by adding suitable substituents and
alculated their propriety using Eqs. (1) and (2).
.4.  Proposed  novel  compounds
The values of the parameters obtained by DFT calcu-
ations for the proposed compounds with an association
onstant for DNA drug binding properties (log(K))
ased on the information derived from Eqs. (1) and (2)
Table 6).
From the predicted association constant (Log K) for
he drug-DNA propriety (Table 6), it has been observed
hat the designed compounds (X13, X14, X15, X16, X17
nd X18) have higher Log K  values than the existing com-
ounds in the case of the 31 studied compounds (Table 1).
dditionally, the designed compounds, X1, have lower
og K  values than the existing compounds.
.  Conclusion
Multiple linear and non-linear regressions were used
o construct a quantitative structure-propriety relation
odel of 9-aniliioacridine derivatives for their DNA drug
inding proprieties. The two regression methods were
ompared and had a substantially better predictive capa-
ility with a greater power. The results show that the
odels proposed in this paper can predict the associa-
ion constant for drug-DNA values accurately and that
he selected electronic parameters (lowest unoccupied
olecular orbital energy, ELUMO, electrophilicity index,
, and activation energy, Ea), which are sufficiently rich
n electronic information to encode structural features,
ould be used with other descriptors in the develop-
ent of predictive QSPR models. The accuracy and
redictability of the proposed models were illustrated
y comparing the key statistical terms r  or r2 for the
[ity for Science 10 (2016) 868–876 875
two models (Table 3), and the predictive powers of the
equations were validated by an external test set (Table 5).
We conclude that the most important finding from this
research is that we have been able to design and propose
new compounds with higher or lower values than exist-
ing compounds (Table 6) by adding suitable substituents
by calculating their propriety using the regression equa-
tions. Consequently, the proposed models will reduce the
time and cost of synthesis as well as the determination
of the DNA drug binding capacity of 9-aniliioacridine
derivatives.
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